Literature DB >> 9746399

Effectiveness of a seventh grade school entry vaccination requirement--statewide and Orange County, Florida, 1997-1998.

.   

Abstract

Vaccine-preventable diseases continue to occur among adolescents (i.e., persons aged 11-21 years). In 1996, the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association published joint recommendations emphasizing appropriate vaccination of adolescents aged 11-12 years who have not been vaccinated with hepatitis B vaccine, a second dose of measles, mumps, and rubella vaccine (MMR), varicella vaccine (if indicated), a booster dose of tetanus and diphtheria toxoids (Td), and other vaccines that may be indicated for certain adolescents. School entry requirements are an effective mechanism for ensuring high vaccination coverage among children. At the start of the 1997-98 school year, an amendment to the Florida Administrative Code (64D-3.011, F.A.C.) was instituted that requires all persons entering seventh grade to be vaccinated with three doses of hepatitis B vaccine, a second dose of MMR, and a Td booster, or to be on schedule for vaccination (i.e., having received at least one dose of hepatitis B vaccine, one dose of MMR, and a Td booster). To determine vaccination coverage among students entering seventh grade in Florida and in Orange County in 1997, CDC, in collaboration with the Florida Department of Health, analyzed state vaccination coverage data. This report summarizes the results of the analysis and indicates that a vaccination requirement for middle school entry can be effective in ensuring vaccination of adolescents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746399

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  Hepatitis B immunization coverage among Vietnamese-American children 3 to 18 years old.

Authors:  C N Jenkins; S J McPhee; C Wong; T Nguyen; G L Euler
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

2.  A middle school immunization law rapidly and substantially increases immunization coverage among adolescents.

Authors:  Francisco Averhoff; Leslie Linton; K Michael Peddecord; Christine Edwards; Wendy Wang; Daniel Fishbein
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

3.  Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade.

Authors:  Elyse Olshen Kharbanda; Melissa S Stockwell; James Colgrove; Karthik Natarajan; Vaughn I Rickert
Journal:  Am J Public Health       Date:  2010-07-15       Impact factor: 9.308

4.  The effect of policy changes on hepatitis A vaccine uptake in Arizona children, 1995-2008.

Authors:  Kacey C Ernst; Kristen Pogreba-Brown; Lisa Rasmussen; Laura M Erhart
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

5.  An evaluation of voluntary 2-dose varicella vaccination coverage in New York City public schools.

Authors:  Margaret K Doll; Jennifer B Rosen; Stephanie R Bialek; Hiram Szeto; Christopher M Zimmerman
Journal:  Am J Public Health       Date:  2014-12-18       Impact factor: 9.308

Review 6.  Active immunization in the United States: developments over the past decade.

Authors:  P H Dennehy
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Endorsement of compulsory HIV vaccination policy among populations at high risk of HIV exposure (LA VOICES).

Authors:  Peter A Newman; Sung-Jae Lee; Ellen T Rudy; Allison Diamant; Naihua Duan; Terry Nakazono; Terry Nakazano; William E Cunningham
Journal:  Prev Sci       Date:  2014-06

8.  Vaccination coverage among foreign-born and U.S.-born adolescents in the United States: Successes and gaps - National Immunization Survey-Teen, 2012-2014.

Authors:  Jessica Healy; Alfonso Rodriguez-Lainz; Laurie D Elam-Evans; Holly A Hill; Sarah Reagan-Steiner; David Yankey
Journal:  Vaccine       Date:  2018-02-23       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.